Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview

1143studies shown

Showing 781-792 of 1,143

Biological study icon

Active Not RecruitingNCT05174273

Neurocognitive Effects of FMT in MDD people with and Without IBS

This summary needs review. Please check the official study record and contact the research team for details.

In Canada

DepressionBiologicalFrom 18 Years to 60 Years

Countries: Canada
Sponsor: Valerie Taylor
Condition: Depression

Behavioral study icon

WithdrawnNCT04654130

Neurofeedback Effectiveness study in PTSD

This summary needs review. Please check the official study record and contact the research team for details.

In Canada

PTSDBehavioralFrom 18 Years to 65 Years

Countries: Canada
Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Condition: PTSD

Other study type icon

CompletedNCT04854785

Neuroinflammation in COVID-19 and Depression

This summary needs review. Please check the official study record and contact the research team for details.

In Canada

DepressionObservationalFrom 18 Years to 80 Years

Countries: Canada
Sponsor: Centre for Addiction and Mental Health
Condition: Depression

Device study icon

CompletedNCT04418011

Neuromodulation of Social Cognitive Circuitry in People With Schizophrenia Spectrum Disorders

This summary needs review. Please check the official study record and contact the research team for details.

In Canada

SchizophreniaDeviceFrom 18 Years to 55 Years

Countries: United States, Canada
Sponsor: Centre for Addiction and Mental Health
Condition: Schizophrenia

Drug study icon

CompletedNCT00216918

Neuropsychological Functioning in Children With Attention-Deficit/Hyperactivity Disorder.

This summary needs review. Please check the official study record and contact the research team for details.

In Canada

ADHDDrugFrom 6 Years to 10 Years

Countries: Canada
Sponsor: Eli Lilly and Company
Condition: ADHD

Drug study icon

CompletedNCT01720095

Niapsan as Add -on Therapy to Antipsychotic Treatment in First Episode Psychosis

This summary needs review. Please check the official study record and contact the research team for details.

In Canada

SchizophreniaDrugFrom 18 Years to 35 Years

Countries: Canada
Sponsor: Nova Scotia Health Authority
Condition: Schizophrenia

Other study type icon

CompletedNCT02514720

Nicotine Metabolizers and [11C]-(+)-PHNO

This summary needs review. Please check the official study record and contact the research team for details.

In Canada

AddictionOtherOver 18 Years

Countries: Canada
Sponsor: Centre for Addiction and Mental Health
Condition: Addiction

Drug study icon

TerminatedNCT02351869

Nitrous Oxide as a Putative Novel Dual-Mechanism Treatment for Bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

In Canada

BipolarityDrugFrom 20 Years to 60 Years

Countries: Canada
Sponsor: Sunnybrook Health Sciences Centre
Condition: Bipolarity

Behavioral study icon

CompletedNCT06638411

Nocebo Education to Reduce the Potential Unintended Harms of Mental Health Awareness

This summary needs review. Please check the official study record and contact the research team for details.

In Canada

ADHDBehavioralFrom 18 Years to 25 Years

Countries: Canada
Sponsor: University of Toronto
Condition: ADHD

Behavioral study icon

WithdrawnNCT04825535

Non-Inferiority RCT Comparing Online and On-Site CBT in MDDi

This summary needs review. Please check the official study record and contact the research team for details.

Remote / online

DepressionBehavioralFrom 18 Years to 60 Years

Countries: Canada
Sponsor: Centre for Addiction and Mental Health
Condition: Depression

Other study type icon

CompletedNCT04593095

Nurturing and Quiet Intervention: NeuroN-QI

This summary needs review. Please check the official study record and contact the research team for details.

In Canada

AnxietyOtherFrom 26 Weeks to 32 Weeks

Countries: Canada
Sponsor: St. Justine's Hospital
Condition: Anxiety

Other study type icon

CompletedNCT06256367

Cariprazine Capsules to Assess Change for Bipolarity

This study is completed in the United States and in Canada. It is testing cariprazine Capsules to Assess Change for Bipolarity.

In Canada

BipolarityObservationalOver 18 Years

Countries: United States, Canada
Sponsor: AbbVie
Condition: Bipolarity

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.